Rwanda Battles Deadly Marburg Virus Outbreak with Global Aid

Rwanda is currently dealing with the first outbreak of Marburg virus disease, a rare and highly lethal hemorrhagic fever that shares similarities with Ebola. Unfortunately, there are no available treatments or vaccines for this disease, and it has a staggering fatality rate of 88%. The country’s health ministry has reported that 26 people have been infected, with 18 currently undergoing treatment and eight having tragically succumbed to the illness.

In response to this crisis, the World Health Organization (WHO) is mobilizing essential medical supplies and dispatching a team of seven global experts in hemorrhagic diseases to provide crucial support to local public health officials. Additionally, the US Centers for Disease Control and Prevention (CDC) is deploying its own team of experts to assist with testing and contact tracing efforts. The CDC has been actively involved in Rwanda since 2002, playing a key role in fortifying the nation’s health system. Unlike some other sub-Saharan African countries, Rwanda possesses a robust public health infrastructure, a factor that the WHO believes will greatly aid in containing the outbreak.

Dr. Matshidiso Moeti, WHO’s regional director for Africa, emphasized the importance of collaborating with national authorities to bolster ongoing containment efforts. Dr. Brian Chirombo, WHO’s representative in Rwanda, expressed confidence in the country’s capacity to swiftly bring the outbreak under control. The Ministry of Health has reassured the public that daily activities can proceed as normal, as all disease hotspots have been identified and appropriate measures have been implemented. The virus has spread to seven of Rwanda’s 30 districts, with over 100 contacts currently being monitored or isolated. Alarmingly, a significant number of the infected individuals are healthcare workers. Marburg virus, which is naturally harbored by fruit bats, is transmitted through contact with the bodily fluids of infected individuals or contaminated materials. Notably, the virus is not airborne, which simplifies containment efforts. Its symptoms can take up to three weeks to manifest and may include rash, fever, vomiting, severe headache, muscle aches, and in severe cases, bleeding and shock. While scientists are actively working on developing vaccines and treatments, the current approach to care is primarily supportive, focusing on rest and fluid intake.

About The Author

Lebone

I hold a Diploma in Journalism and Media Studies from Damelin, where I gained a solid foundation in various aspects of media communication and reporting. My experience includes writing travel articles for “What’s On In Mzansi,” where I had the opportunity to explore and share insights about South Africa’s diverse attractions and cultures. In addition to my writing, I have also worked as a radio host, where I developed my skills in engaging audiences and delivering compelling content. This combination of education and practical experience has equipped me with a comprehensive understanding of the media landscape and storytelling techniques.

See author's posts